Preferred Label : hydrochlorothiazide;

MeSH definition : A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.;

MeSH synonym : hctz; dichlothiazide; dihydrochlorothiazide;

MeSH hyponym : sectrazide; HydroDIURIL; oretic; hypothiazide; esidrix; Esidrex;

MeSH CAS label : 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide;

MeSH Related Number : 58-93-5 (Hydrochlorothiazide);

Registry Number MeSH : 58-93-5;

Wikipedia link : https://en.wikipedia.org/wiki/Hydrochlorothiazide;

Codes EINECS : 200-403-3;

Is substance : O;

UNII : 0J48LPH2TH;

InChIKey : JZUFKLXOESDKRF-UHFFFAOYSA-N;

Details


Main resources

You can consult :

A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.

http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61897454
2021
false
false
false
France
French
administration, oral
summary of product characteristics
package leaflet
telmisartan, hydrochlorothiazide drug combination
antihypertensive agents
telmisartan and diuretics
benzimidazoles
benzoates
hydrochlorothiazide
drug combinations
Telmisartan

---
Certain sulfonamide diuretics and the risk of choroidal effusion with acute myopia and/or acute angle-closure glaucoma
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/infovigilance-produits-sante/mars-2021.html#a10
2021
false
false
false
Canada
French
English
pharmacovigilance note
diuretics
Sulfonamide diuretic (substance)
Choroidal effusion
myopia
glaucoma, angle-closure
acute disease
choroid diseases
acetazolamide
chlorthalidone
hydrochlorothiazide
indapamide
metolazone
sulfonamides

---
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2019/68976a-fra.php
2019
false
false
false
Canada
French
English
hydrochlorothiazide
skin neoplasms
risk
antihypertensive agents
Evidence-Based medicine
sodium chloride symporter inhibitors
pharmacovigilance note
popular works
risk assessment

---
https://www.has-sante.fr/jcms/p_3105003/fr/hydrochlorothiazide-arrow
2019
false
false
false
France
hydrochlorothiazide
administration, oral
hypertension
edema, cardiac
edema
Oedema due to hepatic disease
Oedema due to renal disease
antihypertensive agents
diuretics
sodium chloride symporter inhibitors
adult
evaluation of the transparency committee
hydrochlorothiazide

---
https://www.has-sante.fr/portail/jcms/c_2875371/fr/moduretic
2018
false
false
false
France
amiloride, hydrochlorothiazide drug combination
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
moduretic
amiloride
hydrochlorothiazide
drug combinations

---
https://www.has-sante.fr/portail/jcms/c_2856003/fr/moducren
2018
false
false
false
false
France
French
evaluation of the transparency committee
moducrin
insurance, health, reimbursement
treatment outcome
amiloride
hydrochlorothiazide
timolol
drug combinations

---
https://www.ansm.sante.fr/actualites/medicaments-a-base-dhydrochlorothiazide-information-sur-levaluation-europeenne-dun-signal-de-securite
2018
false
false
false
France
French
pharmacovigilance note
risk
hydrochlorothiazide
antihypertensive agents
sodium chloride symporter inhibitors
skin neoplasms
risk assessment
Observational Studies as Topic

---
https://www.ansm.sante.fr/actualites/risque-de-cancers-de-la-peau-associes-aux-medicaments-contenant-de-lhydrochlorothiazide
2018
false
false
false
France
French
skin neoplasms
hydrochlorothiazide
pharmacovigilance note
sodium chloride symporter inhibitors
antihypertensive agents
lip neoplasms
risk
carcinoma, basal cell
carcinoma, squamous cell
administration, oral

---
https://www.has-sante.fr/portail/jcms/c_2876779/fr/co-renitec
2018
false
true
false
France
hydrochlorothiazide
drug combinations
hypertension
enalapril and diuretics
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
enalapril

---
https://ansm.sante.fr/uploads/2021/01/07/dhpc-181106-hydrochlorothiazide.pdf
2018
false
false
false
France
French
pharmacovigilance note
hydrochlorothiazide
skin neoplasms
information dissemination
carcinoma, basal cell
carcinoma, squamous cell
risk
drug combinations
antihypertensive agents

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/1157
2017
false
false
false
Canada
French
journal article
antihypertensive agents
comparative effectiveness research
hypertension
canada
sodium chloride symporter inhibitors
diuretics
treatment outcome
Evidence-Based medicine
low-ceiling diuretics, thiazides
low-ceiling diuretics, excl. thiazides
indapamide
arterial pressure
chlorthalidone
hydrochlorothiazide

---
https://www.has-sante.fr/portail/jcms/c_2777965/fr/micardisplus
2017
false
false
false
France
French
evaluation of the transparency committee
Micardis-HCT
telmisartan, hydrochlorothiazide drug combination
drug combinations
treatment outcome
insurance, health, reimbursement
hypertension
telmisartan and diuretics
hydrochlorothiazide
benzimidazoles
benzoates
Telmisartan

---
http://www.has-sante.fr/portail/jcms/c_2756577/fr/zofenilduo-coteoula
http://www.has-sante.fr/portail/jcms/c_1256029/zofenilduo
2017
false
false
France
French
evaluation of the transparency committee
treatment outcome
captopril
administration, oral
insurance, health, reimbursement
drug combinations
hydrochlorothiazide
antihypertensive agents
diuretics
zofenopril, calcium salt, (1(R*),2alpha,4alpha)-isomer
zofenopril
angiotensin-converting enzyme inhibitors
zofenopril and diuretics
hypertension

---
http://www.has-sante.fr/portail/jcms/c_2658537/fr/alteisduo
2016
false
France
French
treatment outcome
intestinal diseases
angiotensin II type 1 receptor blockers
antihypertensive agents
Olmesartan Medoxomil
Olmesartan Medoxomil
drug combinations
antihypertensive agents
angiotensin II type 1 receptor blockers
hydrochlorothiazide
diuretics
insurance, health, reimbursement
administration, oral
olmesartan medoxomil and diuretics
hypertension
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2632877/fr/esidrex
2016
true
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
administration, oral
sodium chloride symporter inhibitors
antihypertensive agents
diuretics
hydrochlorothiazide
hydrochlorothiazide
edema
hypertension
drug therapy, combination

---
http://www.has-sante.fr/portail/jcms/c_2588548/fr/briazide-cibadrex
2016
true
France
French
treatment outcome
benazepril hydrochloride
administration, oral
drug combinations
hydrochlorothiazide
benazepril
antihypertensive agents
diuretics
angiotensin-converting enzyme inhibitors
sodium chloride symporter inhibitors
benazepril and diuretics
benzazepines
insurance, health, reimbursement
hypertension
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2658549/fr/hytacand
http://www.has-sante.fr/portail/jcms/c_1036303/hytacand
http://www.has-sante.fr/portail/jcms/c_400717/fr/hytacand-8-mg/12-5-mg-comprime-plaquettes-thermoformees-pvc-aluminium-pvdc-de-28-comprimes-code-cip-353-911-3
2016
false
France
French
adult
diuretics
hydrochlorothiazide
tetrazoles
angiotensin II type 1 receptor blockers
benzimidazoles
biphenyl compounds
drug combinations
antihypertensive agents
candesartan cilexetil
candesartan and diuretics
administration, oral
insurance, health, reimbursement
hypertension
sodium chloride symporter inhibitors
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2658516/fr/cokenzen
http://www.has-sante.fr/portail/jcms/c_1067916/cokenzen
2016
false
France
French
evaluation of the transparency committee
adult
hypertension
antihypertensive agents
angiotensin II type 1 receptor blockers
sodium chloride symporter inhibitors
diuretics
hydrochlorothiazide
candesartan cilexetil
administration, oral
drug combinations
insurance, health, reimbursement
candesartan and diuretics
benzimidazoles
biphenyl compounds
tetrazoles

---
http://www.has-sante.fr/portail/jcms/c_2620024/fr/fortzaar-hyzaar
http://www.has-sante.fr/portail/jcms/c_1036318/hyzaar-fortzaar
2016
false
France
French
losartan potassium
treatment outcome
hydrochlorothiazide, losartan drug combination
drug combinations
hydrochlorothiazide
diuretics
losartan
angiotensin II type 1 receptor blockers
administration, oral
sodium chloride symporter inhibitors
antihypertensive agents
losartan and diuretics
insurance, health, reimbursement
hypertension
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2609226/fr/zestoretic
http://www.has-sante.fr/portail/jcms/c_1026413/zestoretic
http://www.has-sante.fr/portail/jcms/c_399475/fr/zestoretic-20-mg/12-5mg-comprimes-secables-boite-de-28
2016
false
France
French
treatment outcome
lisinopril
drug combinations
hydrochlorothiazide
administration, oral
hydrochlorothiazide, lisinopril drug combination
insurance, health, reimbursement
diuretics
angiotensin-converting enzyme inhibitors
lisinopril and diuretics
antihypertensive agents
hypertension
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2626273/fr/cotareg
http://www.has-sante.fr/portail/jcms/c_1036309/cotareg
http://www.has-sante.fr/portail/jcms/c_455314/fr/cotareg
2016
false
France
French
Valsartan
hypertension
angiotensin II type 1 receptor blockers
insurance, health, reimbursement
valsartan and diuretics
hydrochlorothiazide
diuretics
drug combinations
administration, oral
antihypertensive agents
sodium chloride symporter inhibitors
treatment outcome
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2024575/fr/lodoz
http://www.has-sante.fr/portail/jcms/c_854106/lodoz
http://www.has-sante.fr/portail/display.jsp?id=c_400099
2015
false
France
French
hypertension
bisoprolol and thiazides
administration, oral
drug combinations
bisoprolol, hydrochlorothiazide drug combination
bisoprolol
hydrochlorothiazide
insurance, health, reimbursement
antihypertensive agents
evaluation of the transparency committee
bisoprolol fumarate (2:1) salt, (+-)-Isomer

---
http://www.has-sante.fr/portail/jcms/c_2017378/fr/wytens
http://www.has-sante.fr/portail/jcms/c_854091/wytens
2015
false
France
French
administration, oral
bisoprolol and thiazides
hypertension
hydrochlorothiazide
antihypertensive agents
bisoprolol
drug combinations
insurance, health, reimbursement
sodium chloride symporter inhibitors
adrenergic beta-1 receptor antagonists
bisoprolol, hydrochlorothiazide drug combination
bisoprolol fumarate (2:1) salt, (+-)-Isomer
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2022230/fr/prinzide
http://www.has-sante.fr/portail/jcms/c_854100/prinzide
2015
false
France
French
hydrochlorothiazide, lisinopril drug combination
lisinopril and diuretics
hypertension
hydrochlorothiazide
lisinopril
antihypertensive agents
drug combinations
diuretics
angiotensin-converting enzyme inhibitors
administration, oral
insurance, health, reimbursement
sodium chloride symporter inhibitors
evaluation of the transparency committee
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2012490/fr/foziretic
http://www.has-sante.fr/portail/jcms/c_937956/foziretic
http://www.has-sante.fr/portail/jcms/c_400190/fr/foziretic-20-mg/12-5-mg-comprime-secable-boite-de-28-comprimes-code-cip-341-035-9
2015
false
France
French
insurance, health, reimbursement
hypertension
fosinopril
drug combinations
hydrochlorothiazide
antihypertensive agents
angiotensin-converting enzyme inhibitors
administration, oral
diuretics
fosinopril and diuretics
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2036407/fr/alteisduo
http://www.has-sante.fr/portail/jcms/c_2036407/fr/alteisduo-olmesartan/hydrochlorothiazide
2015
false
France
French
treatment outcome
intestinal diseases
angiotensin II type 1 receptor blockers
antihypertensive agents
guidelines for drug use
Olmesartan Medoxomil
Olmesartan Medoxomil
drug combinations
antihypertensive agents
angiotensin II type 1 receptor blockers
hydrochlorothiazide
diuretics
insurance, health, reimbursement
administration, oral
olmesartan medoxomil and diuretics
hypertension
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2022090/fr/temeritduo
2015
true
France
French
nebivolol hydrochloride
Nebivolol
drug combinations
administration, oral
antihypertensive agents
hydrochlorothiazide
diuretics
sodium chloride symporter inhibitors
insurance, health, reimbursement
beta blocking agents, selective, and thiazides
hypertension
adrenergic beta-1 receptor antagonists
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2579413/fr/alteisduo
2015
false
France
French
treatment outcome
intestinal diseases
angiotensin II type 1 receptor blockers
antihypertensive agents
Olmesartan Medoxomil
Olmesartan Medoxomil
drug combinations
antihypertensive agents
angiotensin II type 1 receptor blockers
hydrochlorothiazide
diuretics
insurance, health, reimbursement
administration, oral
olmesartan medoxomil and diuretics
hypertension
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1774163/fr/conebilox
http://www.has-sante.fr/portail/jcms/c_901521/conebilox
2014
false
France
French
treatment outcome
Nebivolol
drug combinations
antihypertensive agents
sodium chloride symporter inhibitors
diuretics
hydrochlorothiazide
administration, oral
insurance, health, reimbursement
hypertension
adult
adrenergic beta-1 receptor antagonists
nebivolol and thiazides
evaluation of the transparency committee

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=63032520
2014
summary of product characteristics
hydrochlorothiazide
telmisartan, hydrochlorothiazide drug combination
tablets

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=61344795
2014
summary of product characteristics
tablets
hydrochlorothiazide
telmisartan, hydrochlorothiazide drug combination

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=67193026
2014
summary of product characteristics
telmisartan, hydrochlorothiazide drug combination
hydrochlorothiazide
tablets

---
https://www.ema.europa.eu/medicines/human/EPAR/Tolucombi
2013
United Kingdom
French
English
drug combinations
administration, oral
drug approval
europe
telmisartan, hydrochlorothiazide drug combination
telmisartan and diuretics
hydrochlorothiazide
hydrochlorothiazide
angiotensin II type 1 receptor blockers
angiotensin II type 1 receptor blockers
diuretics
diuretics
adult
hypertension
antihypertensive agents
antihypertensive agents
sodium chloride symporter inhibitors
sodium chloride symporter inhibitors
Product containing precisely hydrochlorothiazide 12.5 milligram and telmisartan 40 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely hydrochlorothiazide 12.5 milligram and telmisartan 80 milligram/1 each conventional release oral tablet (clinical drug)
drugs, generic
therapeutic equivalency
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
summary of product characteristics
package leaflet
drug evaluation
syndication feed
benzimidazoles
benzimidazoles
benzoates
benzoates
Telmisartan
Telmisartan
telmisartan, hydrochlorothiazide drug combination

---
https://www.ema.europa.eu/medicines/human/EPAR/Actelsar-HCT
2013
United Kingdom
French
English
drug combinations
administration, oral
therapeutic equivalency
drug approval
europe
drugs, generic
telmisartan, hydrochlorothiazide drug combination
telmisartan and diuretics
angiotensin II type 1 receptor blockers
angiotensin II type 1 receptor blockers
hydrochlorothiazide
hydrochlorothiazide
antihypertensive agents
antihypertensive agents
diuretics
diuretics
sodium chloride symporter inhibitors
sodium chloride symporter inhibitors
hypertension
summary of product characteristics
adult
aged
Product containing precisely hydrochlorothiazide 12.5 milligram and telmisartan 40 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely hydrochlorothiazide 12.5 milligram and telmisartan 80 milligram/1 each conventional release oral tablet (clinical drug)
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
package leaflet
drug evaluation
syndication feed
benzimidazoles
benzimidazoles
benzoates
benzoates
Telmisartan
Telmisartan
telmisartan, hydrochlorothiazide drug combination

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68045361
2012
France
summary of product characteristics
package leaflet
amiloride
tablets
amiloride, hydrochlorothiazide drug combination
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69688360
2012
France
summary of product characteristics
package leaflet
captopril
hydrochlorothiazide
tablets
captopril, hydrochlorothiazide drug combination

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61728237
2012
France
summary of product characteristics
package leaflet
Amiloride Hydrochloride
tablets
amiloride, hydrochlorothiazide drug combination
amiloride
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65717163
2012
France
summary of product characteristics
package leaflet
lisinopril
hydrochlorothiazide
tablets
hydrochlorothiazide, lisinopril drug combination

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67169242
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66793356
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65739633
2012
France
summary of product characteristics
package leaflet
bisoprolol
bisoprolol fumarate
bisoprolol, hydrochlorothiazide drug combination
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65694191
2012
France
summary of product characteristics
package leaflet
bisoprolol fumarate
tablets
hydrochlorothiazide
bisoprolol
bisoprolol, hydrochlorothiazide drug combination

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65278054
2012
France
summary of product characteristics
package leaflet
bisoprolol, hydrochlorothiazide drug combination
bisoprolol
tablets
bisoprolol fumarate
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61946531
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide
bisoprolol, hydrochlorothiazide drug combination
bisoprolol
bisoprolol fumarate

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68482208
2012
France
summary of product characteristics
package leaflet
bisoprolol
bisoprolol fumarate
tablets
hydrochlorothiazide
bisoprolol, hydrochlorothiazide drug combination

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67102553
2012
France
summary of product characteristics
package leaflet
bisoprolol
bisoprolol, hydrochlorothiazide drug combination
bisoprolol fumarate
hydrochlorothiazide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61297491
2012
France
summary of product characteristics
package leaflet
bisoprolol fumarate
tablets
bisoprolol, hydrochlorothiazide drug combination
hydrochlorothiazide
bisoprolol

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65643535
2012
France
summary of product characteristics
package leaflet
bisoprolol
bisoprolol fumarate
tablets
hydrochlorothiazide
bisoprolol, hydrochlorothiazide drug combination

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67135852
2012
France
summary of product characteristics
package leaflet
bisoprolol fumarate
bisoprolol
hydrochlorothiazide
tablets
bisoprolol, hydrochlorothiazide drug combination

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63743120
2012
France
summary of product characteristics
package leaflet
bisoprolol, hydrochlorothiazide drug combination
bisoprolol
hydrochlorothiazide
tablets
bisoprolol fumarate

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69339782
2012
France
summary of product characteristics
package leaflet
bisoprolol, hydrochlorothiazide drug combination
tablets
hydrochlorothiazide
bisoprolol
bisoprolol fumarate

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63806097
2012
France
summary of product characteristics
package leaflet
bisoprolol fumarate
hydrochlorothiazide
bisoprolol, hydrochlorothiazide drug combination
bisoprolol
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65190921
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61385500
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61782612
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66250079
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65079198
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66566668
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65538986
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65912117
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68516393
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide, losartan drug combination
hydrochlorothiazide
tablets
losartan

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67714568
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
losartan
tablets
hydrochlorothiazide, losartan drug combination

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66331314
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide, losartan drug combination
losartan
hydrochlorothiazide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69905668
2012
France
summary of product characteristics
package leaflet
losartan
hydrochlorothiazide
hydrochlorothiazide, losartan drug combination
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60142043
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide, losartan drug combination
hydrochlorothiazide
losartan

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68988369
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide, losartan drug combination
hydrochlorothiazide
losartan
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60560046
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65176633
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64062452
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63240667
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69492664
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68415437
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60512090
2012
France
summary of product characteristics
package leaflet
tablets
candesartan cilexetil
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66617034
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
candesartan cilexetil
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62547777
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
tablets
hydrochlorothiazide, losartan drug combination
losartan

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66983010
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
losartan
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61551089
2012
France
summary of product characteristics
package leaflet
losartan
hydrochlorothiazide
hydrochlorothiazide, losartan drug combination
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60777637
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
losartan
hydrochlorothiazide, losartan drug combination
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61194363
2012
France
summary of product characteristics
package leaflet
tablets
losartan
hydrochlorothiazide, losartan drug combination
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69777040
2012
France
summary of product characteristics
package leaflet
quinapril hydrochloride
hydrochlorothiazide
tablets
Quinapril

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67863626
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62211328
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68522318
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67967062
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65613289
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63174690
2012
France
summary of product characteristics
package leaflet
zofenopril, calcium salt, (1(R*),2alpha,4alpha)-isomer
zofenopril
hydrochlorothiazide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62358463
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide, losartan drug combination
losartan
hydrochlorothiazide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63722489
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65772195
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62871220
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61644248
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65262744
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68582945
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
tablets
Amlodipine Besylate
amlodipine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66704731
2012
France
summary of product characteristics
package leaflet
amlodipine
tablets
hydrochlorothiazide
Amlodipine Besylate

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69531131
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
Amlodipine Besylate
amlodipine
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69895640
2012
France
summary of product characteristics
package leaflet
Amlodipine Besylate
amlodipine
hydrochlorothiazide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69684554
2012
France
summary of product characteristics
package leaflet
Amlodipine Besylate
hydrochlorothiazide
tablets
amlodipine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67815898
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
tablets
amlodipine
Amlodipine Besylate

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63370963
2012
France
summary of product characteristics
package leaflet
tablets
Amlodipine Besylate
hydrochlorothiazide
amlodipine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63460503
2012
France
summary of product characteristics
package leaflet
tablets
Amlodipine Besylate
hydrochlorothiazide
amlodipine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60771292
2012
France
summary of product characteristics
package leaflet
Amlodipine Besylate
hydrochlorothiazide
amlodipine
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68994137
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide
Amlodipine Besylate
amlodipine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64456899
2012
France
summary of product characteristics
package leaflet
tablets
candesartan cilexetil
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65528472
2012
France
summary of product characteristics
package leaflet
candesartan cilexetil
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64676913
2012
France
summary of product characteristics
package leaflet
candesartan cilexetil
hydrochlorothiazide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66525995
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide
candesartan cilexetil

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69690240
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide, losartan drug combination
losartan
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68460165
2012
France
summary of product characteristics
package leaflet
telmisartan, hydrochlorothiazide drug combination
hydrochlorothiazide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66564254
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide
losartan
hydrochlorothiazide, losartan drug combination

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67576284
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
losartan
hydrochlorothiazide, losartan drug combination
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60823593
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide, lisinopril drug combination
hydrochlorothiazide
tablets
lisinopril

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62763458
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
tablets
fosinopril

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64622680
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide
fosinopril

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63383793
2012
France
summary of product characteristics
package leaflet
fosinopril
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67017829
2012
France
summary of product characteristics
package leaflet
fosinopril
hydrochlorothiazide
tablets

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62428328
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide
benazepril

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63830632
2012
France
summary of product characteristics
package leaflet
tablets
hydrochlorothiazide
fosinopril

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60455586
2012
France
summary of product characteristics
package leaflet
quinapril
hydrochlorothiazide
tablets
Quinapril

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60728775
2012
France
summary of product characteristics
package leaflet
benazepril
tablets
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66934180
2012
France
summary of product characteristics
package leaflet
hydrochlorothiazide
tablets
fosinopril

---
https://www.ema.europa.eu/medicines/human/EPAR/PritorPlus
2012
United Kingdom
French
English
syndication feed
telmisartan, hydrochlorothiazide drug combination
treatment outcome
drug evaluation
benzoates
benzimidazoles
hydrochlorothiazide
drug combinations
hypertension
angiotensin II type 1 receptor blockers
adult
antihypertensive agents
telmisartan and diuretics
benzimidazoles
benzoates
drug evaluation
summary of product characteristics
package leaflet
Telmisartan

---
https://www.ema.europa.eu/medicines/human/EPAR/MicardisPlus
2012
United Kingdom
French
English
syndication feed
telmisartan, hydrochlorothiazide drug combination
hypertension
benzimidazoles
benzoates
angiotensin II type 1 receptor blockers
hydrochlorothiazide
diuretics
antihypertensive agents
benzimidazoles
benzoates
angiotensin II type 1 receptor blockers
hydrochlorothiazide
diuretics
antihypertensive agents
treatment outcome
drug evaluation
drug combinations
telmisartan and diuretics
benzimidazoles
benzoates
drug evaluation
summary of product characteristics
package leaflet
Telmisartan

---
https://www.ema.europa.eu/medicines/human/EPAR/Kinzalkomb
2012
United Kingdom
French
English
syndication feed
Contraindications, Procedure
hypertension
hydrochlorothiazide
angiotensin II type 1 receptor blockers
antihypertensive agents
diuretics
pregnancy
breast feeding
hydrochlorothiazide
hydrochlorothiazide
angiotensin II type 1 receptor blockers
antihypertensive agents
antihypertensive agents
diuretics
diuretics
treatment outcome
drug evaluation
drug combinations
telmisartan and diuretics
telmisartan, hydrochlorothiazide drug combination
Product containing precisely hydrochlorothiazide 12.5 milligram and telmisartan 40 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely hydrochlorothiazide 12.5 milligram and telmisartan 80 milligram/1 each conventional release oral tablet (clinical drug)
Kinzalkomb
summary of product characteristics
package leaflet
drug evaluation
Contraindications, Drug
Telmisartan
benzimidazoles
benzimidazoles
benzoates
benzoates
benzimidazoles
benzoates

---
https://www.ema.europa.eu/medicines/human/EPAR/Karvezide
2012
United Kingdom
French
English
syndication feed
hypertension
biphenyl compounds
biphenyl compounds
tetrazoles
tetrazoles
angiotensin II type 1 receptor blockers
angiotensin II type 1 receptor blockers
antihypertensive agents
antihypertensive agents
hydrochlorothiazide
hydrochlorothiazide
diuretics
diuretics
pregnancy
breast feeding
drug interactions
treatment outcome
drug evaluation
tablets
drug combinations
drug approval
drug labeling
drug evaluation, preclinical
irbesartan and diuretics
biphenyl compounds
tetrazoles
drug evaluation
summary of product characteristics
package leaflet
Irbesartan
Irbesartan

---
https://www.ema.europa.eu/medicines/human/EPAR/CoAprovel
2012
United Kingdom
English
French
syndication feed
biphenyl compounds
biphenyl compounds
tetrazoles
tetrazoles
angiotensin II type 1 receptor blockers
angiotensin II type 1 receptor blockers
antihypertensive agents
antihypertensive agents
hydrochlorothiazide
hydrochlorothiazide
diuretics
diuretics
adult
treatment outcome
drug evaluation
drug combinations
administration, oral
hypertension
tablets
drug approval
drug labeling
drug interactions
pregnancy
drug evaluation, preclinical
irbesartan and diuretics
biphenyl compounds
tetrazoles
drug evaluation
summary of product characteristics
package leaflet
Irbesartan
Irbesartan

---
https://www.ema.europa.eu/medicines/human/EPAR/irbesartan-hydrochlorothiazide-zentiva-previously-irbesartan-hydrochlorothiazide-winthrop
2012
false
United Kingdom
French
English
syndication feed
biphenyl compounds
tetrazoles
angiotensin II type 1 receptor blockers
antihypertensive agents
hydrochlorothiazide
diuretics
hypertension
biphenyl compounds
tetrazoles
angiotensin II type 1 receptor blockers
antihypertensive agents
hydrochlorothiazide
diuretics
adult
pregnancy
breast feeding
drug evaluation
treatment outcome
drug labeling
drug approval
drug combinations
tablets
drug interactions
drug evaluation, preclinical
irbesartan and diuretics
biphenyl compounds
tetrazoles
drug evaluation
package leaflet
summary of product characteristics
Irbesartan
Irbesartan

---
http://www.has-sante.fr/portail/display.jsp?id=c_532065
http://www.has-sante.fr/portail/jcms/c_1323134/coaprovel
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-10/coaprovel_03102012_avis_ct12427.pdf
2012
France
French
drug combinations
sodium chloride symporter inhibitors
antihypertensive agents
diuretics
hydrochlorothiazide
angiotensin II type 1 receptor blockers
irbesartan and diuretics
hypertension
adult
administration, oral
insurance, health, reimbursement
evaluation of the transparency committee
Irbesartan
biphenyl compounds
tetrazoles

---
https://www.ema.europa.eu/medicines/human/EPAR/Rasilez-HCT
2012
United Kingdom
French
English
syndication feed
antihypertensive agents
amides
diuretics
fumarates
hydrochlorothiazide
drug combinations
hydrochlorothiazide
amides
fumarates
tablets
administration, oral
adult
drug approval
aliskiren
aliskiren
breast feeding
diuretics
renin
drug evaluation, preclinical
treatment outcome
drug labeling
aged
drug interactions
pregnancy
aliskiren and hydrochlorothiazide
amides
fumarates
package leaflet
drug evaluation
summary of product characteristics

---
https://www.ema.europa.eu/medicines/human/EPAR/Copalia-HCT
2012
false
United Kingdom
English
French
syndication feed
Valsartan
Valsartan
antihypertensive agents
amlodipine
calcium channel blockers
sodium chloride symporter inhibitors
diuretics
hydrochlorothiazide
amlodipine
hydrochlorothiazide
antihypertensive agents
angiotensin II type 1 receptor blockers
angiotensin II type 1 receptor blockers
diuretics
calcium channel blockers
sodium chloride symporter inhibitors
tablets
administration, oral
adult
drug approval
drug labeling
treatment outcome
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
drug combinations
valsartan, amlodipine and hydrochlorothiazide
Amlodipine Besylate
Product containing amlodipine and hydrochlorothiazide and valsartan (medicinal product)
summary of product characteristics
drug evaluation
package leaflet

---
https://www.ema.europa.eu/medicines/human/EPAR/Imprida-HCT
2012
false
United Kingdom
English
French
syndication feed
Valsartan
Valsartan
antihypertensive agents
amlodipine
calcium channel blockers
sodium chloride symporter inhibitors
diuretics
hydrochlorothiazide
antihypertensive agents
amlodipine
calcium channel blockers
sodium chloride symporter inhibitors
diuretics
hydrochlorothiazide
angiotensin II type 1 receptor blockers
angiotensin II type 1 receptor blockers
drug combinations
drug labeling
treatment outcome
tablets
administration, oral
adult
drug approval
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
valsartan, amlodipine and hydrochlorothiazide
Amlodipine Besylate
summary of product characteristics
drug evaluation
package leaflet

---
https://www.ema.europa.eu/medicines/human/EPAR/Exforge-HCT
2012
false
United Kingdom
French
English
syndication feed
Valsartan
Valsartan
drug labeling
treatment outcome
drug approval
administration, oral
adult
aged
diuretics
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
angiotensin II type 1 receptor blockers
amlodipine
antihypertensive agents
sodium chloride symporter inhibitors
hydrochlorothiazide
amlodipine
antihypertensive agents
sodium chloride symporter inhibitors
calcium channel blockers
diuretics
hydrochlorothiazide
angiotensin II type 1 receptor blockers
calcium channel blockers
drug combinations
valsartan, amlodipine and hydrochlorothiazide
exforge HCT
Amlodipine Besylate
summary of product characteristics
package leaflet
drug evaluation

---
https://www.ema.europa.eu/medicines/human/EPAR/Dafiro-HCT
2012
false
United Kingdom
English
French
syndication feed
Valsartan
Valsartan
breast feeding
drug evaluation, preclinical
drug combinations
antihypertensive agents
amlodipine
calcium channel blockers
sodium chloride symporter inhibitors
diuretics
hydrochlorothiazide
antihypertensive agents
amlodipine
angiotensin II type 1 receptor blockers
angiotensin II type 1 receptor blockers
calcium channel blockers
sodium chloride symporter inhibitors
diuretics
hydrochlorothiazide
drug approval
drug labeling
treatment outcome
tablets
administration, oral
adult
aged
drug interactions
pregnancy
valsartan, amlodipine and hydrochlorothiazide
Amlodipine Besylate
Product containing amlodipine and hydrochlorothiazide and valsartan (medicinal product)
drug evaluation
summary of product characteristics
package leaflet

---
https://www.ema.europa.eu/medicines/human/EPAR/irbesartanhydrochlorothiazide-teva
2012
false
United Kingdom
French
English
syndication feed
drug approval
treatment outcome
drug labeling
drug interactions
pregnancy
biphenyl compounds
biphenyl compounds
tetrazoles
tetrazoles
irbesartan and diuretics
drug combinations
angiotensin II type 1 receptor blockers
angiotensin II type 1 receptor blockers
antihypertensive agents
antihypertensive agents
hydrochlorothiazide
hydrochlorothiazide
diuretics
diuretics
tablets
administration, oral
drugs, generic
adult
breast feeding
sodium chloride symporter inhibitors
sodium chloride symporter inhibitors
drug evaluation, preclinical
biphenyl compounds
tetrazoles
drug evaluation
package leaflet
summary of product characteristics
Irbesartan
Irbesartan

---
http://www.has-sante.fr/portail/jcms/c_1298547/ecazide
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-09/ecazide_05092012_avis_ct_12382.pdf
http://www.has-sante.fr/portail/jcms/c_594460/ecazide
2012
France
French
captopril, hydrochlorothiazide drug combination
administration, oral
drug combinations
captopril
hydrochlorothiazide
diuretics
antihypertensive agents
angiotensin-converting enzyme inhibitors
insurance, health, reimbursement
captopril and diuretics
hypertension
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1298535/captea
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-09/captea_05092012_avis_ct_12386.pdf
http://www.has-sante.fr/portail/jcms/c_594488/captea
2012
France
French
captopril
hydrochlorothiazide
drug combinations
diuretics
angiotensin-converting enzyme inhibitors
antihypertensive agents
hypertension
administration, oral
insurance, health, reimbursement
captopril and diuretics
evaluation of the transparency committee
captopril, hydrochlorothiazide drug combination

---
http://www.has-sante.fr/portail/jcms/c_1296196/moduretic
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-09/moduretic_05092012_avis_ct_12362.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_614742
2012
France
French
Amiloride Hydrochloride
evaluation of the transparency committee
sodium chloride symporter inhibitors
drug combinations
tablets
hydrochlorothiazide
diuretics
amiloride
amiloride, hydrochlorothiazide drug combination
administration, oral
hydrochlorothiazide and potassium-sparing agents
insurance, health, reimbursement
antihypertensive agents
hypertension
edema
ascites
diuretics, potassium sparing

---
http://www.has-sante.fr/portail/jcms/c_1339912/prestole
http://www.has-sante.fr/portail/upload/docs/evamed/CT-12584_PRESTOLE_21112012_CT12584.pdf
http://www.has-sante.fr/portail/jcms/c_594456/prestole
2012
France
French
evaluation of the transparency committee
hydrochlorothiazide and potassium-sparing agents
hypertension
hydrochlorothiazide-triamterene
drug combinations
hydrochlorothiazide
triamterene
diuretics
antihypertensive agents
sodium chloride symporter inhibitors
administration, oral
insurance, health, reimbursement
diuretics, potassium sparing

---
http://www.has-sante.fr/portail/jcms/c_1251937/moducren
http://www.has-sante.fr/portail/display.jsp?id=c_603246
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-06/moducren_23052012_avis_ct12204.pdf
2012
France
French
drug combinations
tablets
Amiloride Hydrochloride
sodium chloride symporter inhibitors
antihypertensive agents
moducrin
adrenergic beta-antagonists
hydrochlorothiazide
timolol
diuretics
amiloride
insurance, health, reimbursement
timolol, thiazides and other diuretics
hypertension
administration, oral
timolol maleate
evaluation of the transparency committee
diuretics, potassium sparing

---
http://www.has-sante.fr/portail/jcms/c_1295462/co-renitec
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-09/corenitec_05092012_avis_ct_12363.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_603032
2012
France
French
sodium chloride symporter inhibitors
hydrochlorothiazide
angiotensin-converting enzyme inhibitors
diuretics
enalapril
antihypertensive agents
insurance, health, reimbursement
administration, oral
drug combinations
enalapril and diuretics
hypertension
tablets
enalapril maleate
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_538705
http://www.has-sante.fr/portail/jcms/c_1264441/pritorplus
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-07/pritor_plus_20062012_avis_ct_12096.pdf
2012
France
French
telmisartan, hydrochlorothiazide drug combination
administration, oral
drug combinations
hydrochlorothiazide
antihypertensive agents
diuretics
sodium chloride symporter inhibitors
angiotensin II type 1 receptor blockers
telmisartan and diuretics
insurance, health, reimbursement
hypertension
tablets
benzimidazoles
benzoates
evaluation of the transparency committee
Telmisartan

---
https://www.ema.europa.eu/medicines/human/EPAR/Ifirmacombi
2012
false
United Kingdom
French
English
syndication feed
hydrochlorothiazide
drug combinations
hydrochlorothiazide
antihypertensive agents
antihypertensive agents
angiotensin II type 1 receptor blockers
angiotensin II type 1 receptor blockers
administration, oral
drugs, generic
irbesartan and diuretics
sodium chloride symporter inhibitors
sodium chloride symporter inhibitors
diuretics
diuretics
adult
pregnancy
drug approval
treatment outcome
drug interactions
hypertension
drug evaluation, preclinical
Product containing hydrochlorothiazide and irbesartan (medicinal product)
summary of product characteristics
package leaflet
drug evaluation
Irbesartan
Irbesartan
biphenyl compounds
biphenyl compounds
tetrazoles
tetrazoles

---
https://www.ema.europa.eu/medicines/human/EPAR/Rasitrio
2012
false
United Kingdom
English
French
drug evaluation
summary of product characteristics
package leaflet
syndication feed
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug)
Product containing aliskiren and amlodipine and hydrochlorothiazide (medicinal product)
amides
amides
fumarates
fumarates
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
hydrochlorothiazide
aliskiren
amlodipine
drug combinations
aliskiren
amlodipine
hydrochlorothiazide
antihypertensive agents
antihypertensive agents
renin
aliskiren, amlodipine and hydrochlorothiazide
calcium channel blockers
calcium channel blockers
administration, oral
adult
hypertension
drug approval
treatment outcome
diuretics
diuretics
sodium chloride symporter inhibitors
sodium chloride symporter inhibitors
vasodilator agents
vasodilator agents
Amlodipine Besylate

---
http://www.has-sante.fr/portail/jcms/c_944504/exforge-hct
http://www.has-sante.fr/portail/jcms/c_1250041/exforge-hct
2012
false
France
French
evaluation of the transparency committee
Valsartan
exforge HCT
drug combinations
administration, oral
insurance, health, reimbursement
hydrochlorothiazide
amlodipine
Amlodipine Besylate
valsartan, amlodipine and hydrochlorothiazide
hypertension
adult
aged
treatment outcome
clinical trials, phase iii as topic
antihypertensive agents

---
http://www.has-sante.fr/portail/jcms/c_1254524/coteoula
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-06/coteoula_23052012_avis_ct_12023.pdf
http://www.has-sante.fr/portail/jcms/c_400648/coteoula-30-mg/12-5-mg-comprime-pellicule-28-comprimes-sous-plaquettes-thermoformees-pvdc/pvc/aluminium-code-cip-368-175-6-100-comprimes-sous-plaquettes-thermoformees-pvdc/pvc/aluminium-cip-566-560-3
2012
France
French
evaluation of the transparency committee
drug combinations
administration, oral
hydrochlorothiazide
zofenopril, calcium salt, (1(R*),2alpha,4alpha)-isomer
zofenopril
sodium chloride symporter inhibitors
diuretics
antihypertensive agents
hypertension
insurance, health, reimbursement
zofenopril and diuretics
angiotensin-converting enzyme inhibitors
captopril

---
http://www.has-sante.fr/portail/jcms/c_1294042/exforge-hct-synthese-28032012
http://www.has-sante.fr/portail/jcms/c_1251529/exforge-hct-28032012-avis-ct11985
http://www.has-sante.fr/portail/jcms/c_1294106/exforge-hct-association-fixe-amlodipine/valsartan/hydrochlorothiazide
2012
false
France
French
evaluation of the transparency committee
guidelines for drug use
Valsartan
antihypertensive agents
diuretics
hypertension
valsartan, amlodipine and hydrochlorothiazide
Amlodipine Besylate
adult
aged
randomized controlled trials as topic
diastolic pressure
systolic pressure
blood pressure
hydrochlorothiazide
exforge HCT
drug combinations
administration, oral
insurance, health, reimbursement
treatment outcome
amlodipine
comparative study

---
https://www.ema.europa.eu/medicines/human/EPAR/Sprimeo-HCT
2011
United Kingdom
English
French
drug evaluation
package leaflet
summary of product characteristics
syndication feed
aliskiren
hydrochlorothiazide
drug combinations
administration, oral
drug approval
treatment outcome
aliskiren
amides
amides
fumarates
fumarates
renin
antihypertensive agents
antihypertensive agents
hydrochlorothiazide
diuretics
diuretics
sodium chloride symporter inhibitors
sodium chloride symporter inhibitors
hypertension
aliskiren and hydrochlorothiazide
adult
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
http://www.lecrat.eu/?s=Hydrochlorothiazide
2011
France
drug information
hydrochlorothiazide

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-02/briazide_-_ct-9546.pdf
http://www.has-sante.fr/portail/jcms/c_1024740/briazide
2011
France
French
benazepril hydrochloride
administration, oral
drug combinations
hydrochlorothiazide
benazepril
antihypertensive agents
diuretics
angiotensin-converting enzyme inhibitors
sodium chloride symporter inhibitors
benazepril and diuretics
benzazepines
insurance, health, reimbursement
hypertension
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_473949
http://www.has-sante.fr/portail/jcms/c_1172425/cibadrex
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-01/cibadrex_14-12-2011_avis_ct_11841.pdf
2011
France
French
benazepril hydrochloride
benzazepines
drug combinations
benazepril
administration, oral
insurance, health, reimbursement
hydrochlorothiazide
antihypertensive agents
diuretics
angiotensin-converting enzyme inhibitors
benazepril and diuretics
hypertension
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_921638/temerit-duo-association-fixe-de-nebivolol-et-dhydrochlorothiazide-antihypertenseur
2010
false
false
false
false
Haute Autorité de santé
France
evaluation of the transparency committee
association
antihypertensive agents
hydrochlorothiazide

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63870751
2010
France
French
hydrochlorothiazide-triamterene
hydrochlorothiazide-triamterene
hydrochlorothiazide
hydrochlorothiazide
triamterene
triamterene
diuretics
diuretics
antihypertensive agents
antihypertensive agents
hydrochlorothiazide and potassium-sparing agents
sodium chloride symporter inhibitors
sodium chloride symporter inhibitors
drug combinations
capsules
administration, oral
hypertension
drug interactions
pregnancy
breast feeding
summary of product characteristics
package leaflet
diuretics, potassium sparing

---
http://www.aboutkidshealth.ca/Fr/HealthAZ/Drugs/Pages/Spironolactone-Hydrochlorothiazide.aspx
2010
false
Canada
French
English
buthiazide, spironolactone drug combination
child
hydrochlorothiazide
drug combinations
spironolactone
spironolactone
hydrochlorothiazide
diuretics
diuretics
hydrochlorothiazide and potassium-sparing agents
administration, oral
buthiazide, spironolactone drug combination
drug information
patient education handout
diuretics, potassium sparing

---
http://www.has-sante.fr/portail/jcms/c_918261/koretic
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-01/koretic_-_ct-7396.pdf
2010
France
French
hydrochlorothiazide
drug combinations
administration, oral
antihypertensive agents
tetrahydroisoquinolines
diuretics
angiotensin-converting enzyme inhibitors
sodium chloride symporter inhibitors
quinapril and diuretics
insurance, health, reimbursement
hypertension
tetrahydroisoquinolines
evaluation of the transparency committee
Quinapril

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-10/cotriatec_-_ct-8575.pdf
http://www.has-sante.fr/portail/jcms/c_990909/cotriatec
2010
France
French
tablets
ramipril
hydrochlorothiazide
drug combinations
administration, oral
antihypertensive agents
diuretics
sodium chloride symporter inhibitors
angiotensin-converting enzyme inhibitors
ramipril and diuretics
insurance, health, reimbursement
hypertension
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2031557/fr/acuilix
http://www.has-sante.fr/portail/jcms/c_923048/acuilix
2010
false
France
French
drug combinations
administration, oral
antihypertensive agents
angiotensin-converting enzyme inhibitors
tetrahydroisoquinolines
hydrochlorothiazide
diuretics
sodium chloride symporter inhibitors
quinapril and diuretics
insurance, health, reimbursement
hypertension
tetrahydroisoquinolines
evaluation of the transparency committee
Quinapril

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-04/exforge_hct-_ct-7151.pdf
http://www.has-sante.fr/portail/jcms/c_966568/exforge-hct-association-fixe-damlodipine/valsartan/hydrochlorothiazide-antihypertenseur
2010
false
France
French
Valsartan
drug combinations
amlodipine
hydrochlorothiazide
administration, oral
insurance, health, reimbursement
valsartan, amlodipine and hydrochlorothiazide
hypertension
adult
treatment outcome
antihypertensive agents
exforge HCT
Amlodipine Besylate
evaluation of the transparency committee
guidelines for drug use

---
http://www.has-sante.fr/portail/jcms/c_962483/alteisduo
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-06/alteis_duo_-_ct-8132.pdf
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-09/alteisduo_ct_8132.pdf
2010
false
France
French
English
Olmesartan Medoxomil
olmesartan medoxomil and diuretics
insurance, health, reimbursement
drug combinations
hydrochlorothiazide
administration, oral
diuretics
angiotensin II type 1 receptor blockers
antihypertensive agents
hypertension
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-06/coolmetec_-_ct-8103.pdf
http://www.has-sante.fr/portail/jcms/c_962466/coolmetec
2010
false
France
French
Olmesartan Medoxomil
angiotensin II type 1 receptor blockers
treatment outcome
drug combinations
olmesartan medoxomil and diuretics
administration, oral
hydrochlorothiazide
insurance, health, reimbursement
hypertension
diuretics
evaluation of the transparency committee

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66298483
http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=66298483&typedoc=R&ref=R0164988.htm
http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=66298483&typedoc=N&ref=N0164988.htm
2010
France
French
zofenopril and diuretics
zofenopril
drug combinations
zofenopril
administration, oral
angiotensin-converting enzyme inhibitors
angiotensin-converting enzyme inhibitors
antihypertensive agents
antihypertensive agents
hydrochlorothiazide
hydrochlorothiazide
captopril
diuretics
diuretics
zofenopril, calcium salt, (1(R*),2alpha,4alpha)-isomer
zofenopril, calcium salt, (1(R*),2alpha,4alpha)-isomer
package leaflet
summary of product characteristics

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69155138
2010
France
French
enalapril and diuretics
hydrochlorothiazide
hydrochlorothiazide
drug combinations
adult
aged
diuretics
diuretics
sodium chloride symporter inhibitors
sodium chloride symporter inhibitors
enalapril
enalapril
antihypertensive agents
antihypertensive agents
angiotensin-converting enzyme inhibitors
angiotensin-converting enzyme inhibitors
tablets
administration, oral
hypertension
drug interactions
pregnancy
breast feeding
enalapril maleate
enalapril maleate
summary of product characteristics
package leaflet

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66153192
2010
false
France
French
tablets
administration, oral
sodium chloride symporter inhibitors
sodium chloride symporter inhibitors
antihypertensive agents
antihypertensive agents
diuretics
diuretics
hydrochlorothiazide
hydrochlorothiazide
hydrochlorothiazide
edema
hypertension
drug interactions
pregnancy
breast feeding
drug therapy, combination
summary of product characteristics
package leaflet

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63343820
2010
France
French
antihypertensive agents
vasodilator agents
adrenergic beta-antagonists
ethanolamines
benzopyrans
hydrochlorothiazide
drug information

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67059059
2010
France
French
benzopyrans
ethanolamines
vasodilator agents
antihypertensive agents
adrenergic beta-antagonists
hydrochlorothiazide
drug information

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61955523
2010
France
French
benzopyrans
antihypertensive agents
vasodilator agents
ethanolamines
adrenergic beta-antagonists
hydrochlorothiazide
drug information

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64676596
2010
France
French
benzopyrans
ethanolamines
hydrochlorothiazide
adrenergic beta-antagonists
vasodilator agents
antihypertensive agents
drug information

---
https://www.ema.europa.eu/medicines/human/EPAR/Irbesartan-Hydrochlorothiazide-BMS
2009
United Kingdom
French
English
syndication feed
biphenyl compounds
tetrazoles
antihypertensive agents
angiotensin II type 1 receptor blockers
hydrochlorothiazide
diuretics
hypertension
tetrazoles
antihypertensive agents
angiotensin II type 1 receptor blockers
hydrochlorothiazide
diuretics
adult
breast feeding
pregnancy
drug combinations
drug approval
drug labeling
treatment outcome
drug evaluation
drug interactions
drug evaluation, preclinical
irbesartan and diuretics
biphenyl compounds
biphenyl compounds
tetrazoles
drug evaluation
package leaflet
summary of product characteristics
Irbesartan
Irbesartan

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Olmetec-Plus_May-27-2009_f.pdf
2009
false
Canada
French
Olmesartan Medoxomil
antihypertensive agents
drug combinations
hydrochlorothiazide
angiotensin II type 1 receptor blockers
treatment outcome
diuretics
tablets
administration, oral
drug evaluation

---
http://www.has-sante.fr/portail/jcms/c_874833/temeritduo
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-11/temerit_duo_-_ct-7110.pdf
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-04/temerit_duo_ct_7110.pdf
2009
false
France
French
English
guidelines for drug use
Nebivolol
drug combinations
administration, oral
antihypertensive agents
hydrochlorothiazide
diuretics
sodium chloride symporter inhibitors
insurance, health, reimbursement
beta blocking agents, selective, and thiazides
hypertension
adrenergic beta-1 receptor antagonists
evaluation of the transparency committee

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64343809
2009
France
French
Amiloride Hydrochloride
Amiloride Hydrochloride
moducrin
timolol, thiazides and other diuretics
tablets
administration, oral
drug combinations
timolol
timolol
hydrochlorothiazide
hydrochlorothiazide
amiloride
amiloride
sodium chloride symporter inhibitors
sodium chloride symporter inhibitors
adrenergic beta-antagonists
adrenergic beta-antagonists
diuretics
diuretics
antihypertensive agents
antihypertensive agents
timolol maleate
timolol maleate
diuretics, potassium sparing
summary of product characteristics
package leaflet

---
https://rmlg.uliege.be/article/1948
2009
Belgium
journal article
renin
aliskiren
hydrochlorothiazide

---
http://www.has-sante.fr/portail/display.jsp?id=c_477444
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-4018_fortzaar_.pdf
2007
France
French
tablets
hydrochlorothiazide, losartan drug combination
drug combinations
administration, oral
losartan
hydrochlorothiazide
insurance, health, reimbursement
antihypertensive agents
diuretics
angiotensin II type 1 receptor blockers
sodium chloride symporter inhibitors
hypertension
losartan and diuretics
treatment outcome
evaluation of the transparency committee

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Altace-HCT_June-14-2007_f.pdf
2007
Canada
French
ramipril
antihypertensive agents
hypertension
hydrochlorothiazide
drug combinations
ramipril and diuretics
drug evaluation

---
https://rmlg.uliege.be/article/1564
2007
false
Belgium
French
Olmesartan Medoxomil
diuretics
sodium chloride symporter inhibitors
hydrochlorothiazide
angiotensin II type 1 receptor blockers
antihypertensive agents
drug combinations
hypertension
treatment outcome
olmesartan medoxomil and diuretics
journal article
drug information

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-4390_micardis_plus_.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_532214
2007
France
French
administration, oral
drug combinations
hydrochlorothiazide
insurance, health, reimbursement
antihypertensive agents
diuretics
sodium chloride symporter inhibitors
angiotensin II type 1 receptor blockers
telmisartan and diuretics
hypertension
tablets
telmisartan, hydrochlorothiazide drug combination
benzimidazoles
benzimidazoles
benzoates
benzoates
evaluation of the transparency committee
Telmisartan

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-3466_coteveten.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_455324
2006
France
French
hydrochlorothiazide
drug combinations
administration, oral
insurance, health, reimbursement
eprosartan mesylate dihydrate
antihypertensive agents
diuretics
sodium chloride symporter inhibitors
eprosartan and diuretics
treatment outcome
hypertension
tablets
angiotensin II type 2 receptor blockers
imidazoles
thiophenes
imidazoles
thiophenes
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_400962
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032542.pdf
2006
false
France
French
Olmesartan Medoxomil
drug combinations
antihypertensive agents
angiotensin II type 1 receptor blockers
hydrochlorothiazide
diuretics
insurance, health, reimbursement
administration, oral
olmesartan medoxomil and diuretics
hypertension
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_456403
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-2894_nisisco.pdf
2006
false
France
French
Valsartan
hydrochlorothiazide
drug combinations
angiotensin II type 1 receptor blockers
antihypertensive agents
valsartan and diuretics
diuretics
insurance, health, reimbursement
administration, oral
hypertension
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_400184
2005
France
French
drug combinations
diuretics
hydrochlorothiazide
tablets
tetrahydroisoquinolines
angiotensin-converting enzyme inhibitors
sodium chloride symporter inhibitors
antihypertensive agents
quinapril and diuretics
evaluation of the transparency committee
Quinapril

---
http://www.has-sante.fr/portail/display.jsp?id=c_400699
2005
France
French
diuretics
hydrochlorothiazide
tetrazoles
angiotensin II type 1 receptor blockers
benzimidazoles
biphenyl compounds
drug combinations
antihypertensive agents
candesartan cilexetil
candesartan and diuretics
benzimidazoles
biphenyl compounds
tetrazoles
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_400267
2005
France
French
drug combinations
antihypertensive agents
sodium chloride symporter inhibitors
diuretics
hydrochlorothiazide
tablets
tetrahydroisoquinolines
angiotensin-converting enzyme inhibitors
quinapril and diuretics
evaluation of the transparency committee
Quinapril

---
http://www.has-sante.fr/portail/display.jsp?id=c_400732
2005
France
evaluation of the transparency committee
captopril
hydrochlorothiazide
captopril, hydrochlorothiazide drug combination

---
http://www.has-sante.fr/portail/display.jsp?id=c_400070
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct031644.pdf
2004
France
French
benazepril
drug combinations
hydrochlorothiazide
administration, oral
benzazepines
antihypertensive agents
hypertension
angiotensin-converting enzyme inhibitors
diuretics
insurance, health, reimbursement
benazepril and diuretics
benazepril hydrochloride
evaluation of the transparency committee

---
https://rmlg.uliege.be/article/960
2003
Belgium
French
dose-response relationship, drug
sodium chloride symporter inhibitors
antihypertensive agents
telmisartan, hydrochlorothiazide drug combination
Kinzalkomb
angiotensin II type 1 receptor blockers
hypertension
drug combinations
telmisartan and diuretics
journal article
drug information
Product containing precisely hydrochlorothiazide 12.5 milligram and telmisartan 80 milligram/1 each conventional release oral tablet (clinical drug)
Telmisartan
benzimidazoles
benzoates
hydrochlorothiazide

---
http://www.has-sante.fr/portail/display.jsp?id=c_399417
2002
France
French
drug combinations
sodium chloride symporter inhibitors
antihypertensive agents
diuretics
hydrochlorothiazide
tablets
angiotensin II type 1 receptor blockers
irbesartan and diuretics
evaluation of the transparency committee
Irbesartan
biphenyl compounds
tetrazoles

---
http://www.has-sante.fr/portail/display.jsp?id=c_398964
2001
France
French
diuretics
hydrochlorothiazide
tablets
tetrazoles
angiotensin II type 1 receptor blockers
benzimidazoles
biphenyl compounds
drug combinations
antihypertensive agents
candesartan cilexetil
candesartan and diuretics
benzimidazoles
biphenyl compounds
tetrazoles
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_398877
2001
France
French
diuretics
hydrochlorothiazide
tablets
tetrazoles
angiotensin II type 1 receptor blockers
benzimidazoles
biphenyl compounds
drug combinations
antihypertensive agents
candesartan cilexetil
candesartan and diuretics
benzimidazoles
biphenyl compounds
tetrazoles
evaluation of the transparency committee

---
Nous contacter.
23/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.